AeroLeads people directory · profile

Tom Stephan Email & Phone Number

Director, DMPK Scientist at Biohaven Pharma
Location: Durham, Connecticut, United States 9 work roles 2 schools
1 work email found @criver.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email t****@criver.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Biohaven Pharma
Role
Director, DMPK Scientist
Location
Durham, Connecticut, United States

Who is Tom Stephan? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Tom Stephan is listed as Director, DMPK Scientist at Biohaven Pharma, based in Durham, Connecticut, United States. AeroLeads shows a work email signal at criver.com and a matched LinkedIn profile for Tom Stephan.

Tom Stephan previously worked as Consultant at Te Stephan Jr., Llc and Director DMPK at Qed Therapeutics. Tom Stephan holds Doctor Of Philosophy (Ph.D.), Pharmacology from University Of Mn-Minneapolis.

Company email context

Email format at Biohaven Pharma

This section adds company-level context without repeating Tom Stephan's masked contact details.

{first_initial}{last}@criver.com
86% confidence

AeroLeads found 1 current-domain work email signal for Tom Stephan. Compare company email patterns before reaching out.

Profile bio

About Tom Stephan

PROFILE SUMMARY AND CORE COMPETENCIESDrug metabolism and pharmacokinetic leader with over 20 years of experience supporting programs in discovery through early clinical pharmacology development. Working with cross-functional team members to contribute to the progression of clinical candidates in the therapeutic areas of oncology, immunology, infectious, cardiovascular, and genetic disease. Dedicated to formulating data driven decisions and ensuring project advancement by providing DMPK strategies that limit potential liabilities and enhance efficiency through productive use of resources that lead to effective timeline management and movement of optimized clinical candidates more rapidly toward approval. Integrated Communication Strategy – simplify questions for practical discussion within multidisciplinary project teams to allow for focused resourcing and timeline management that facilitates the alignment of program strategies with corporate goals Operational Efficiency and Effectiveness – assessment and management of risk(s) to provide go, no go, and cautionary statements to communicate potential success Team Leadership – management of internal and external resources; including direct reports, project teams, CROs, budgets, and information Intelligence gathering – consolidating information from multiple sources to provide guidance for program progression that is competitive, strategic, and instructional Strategic Vision – champion paradigms to support program specific optimization of potential therapeutics Entrepreneurship – apply novel strategies to the existing DMPK screening and sample analysis process to increase understanding and efficiencies

Listed skills include Craft, Art, Engraving, Handmade Jewelry, and 13 others.

Current workplace

Tom Stephan's current company

Company context helps verify the profile and gives searchers a useful next step.

Biohaven Pharma
Biohaven Pharma
Director, DMPK Scientist
9 roles

Tom Stephan work experience

A career timeline built from the work history available for this profile.

Director, Dmpk Scientist

Current
Biohaven Pharma
Oct 2023 - Present

Consultant

Te Stephan Jr., Llc

Director Dmpk

Qed Therapeutics
Dec 2021 - Sep 2022

Principal Scientist Iii, In Vivo

Wilmington, Massachusetts, US

As Study Director, work directly with clients to design and implement DMPK related studies. DMPK subject matter expert responsible for the scientific and logistical matrix management of the technical staff providing formulation and in vivo support.-Principal Investigator and subject matter expert for study conduct, design and interpretation-Primary contact.

Nov 2017 - Nov 2021

Owner, Consultant

Te Stephan Jr, Llc

PHARMACEUTICAL SUPPORTUsing expertise in identifying critical pathways and efficiently focusing limited resources to support reaching key milestones in lead candidate progression our mission is to assist clients in meeting aggressive timelines from lead identification through filing an IND. This is accomplished because we understand that every program is.

Jan 2012 - Nov 2017

Associate Director Of Pharmacology And Toxicology

Dendreon Corporation

Project team leader for small molecule TRPM8 agonist program and Myelovenge protein therapeutic program. Responsible for the Pharmacology and Toxicology Department budget and 1 FTE (chemist). Primary therapeutic area supported was oncology.-Project team leader responsible for development and submission of a TRPM8 small molecule agonist IND (approved in.

Sep 2008 - Jan 2012

Director, Pharmaceutical Development

Branford, CT, US

Direct DMPK, in vitro ADME, bioanalytical and pre-formulation strategies supporting discovery, lead optimization and preclinical development. Responsible for the Pharmaceutical Development Department budget and 6 FTEs. Primary therapeutic areas supported were oncology and immunology.-Designed, implemented and directed the strategy for PK/ADME discovery and.

Feb 2004 - Sep 2008

Principal Scientist, Pre-Clinical

Lead the preclinical DMPK/ADME discovery and lead optimization support activities. Manage 8 FTEs. Primary therapeutic areas supported were oncology and immunology.-Implemented strategies to provide quality in vivo pharmacokinetic support with increased throughput-Championed the implementation of the fundamental strategies used for in vitro ADME support.

Feb 1998 - Feb 2004

Research Associate, Pharmaceutics

Procoter And Gamble Pharmaceuticals

Provided assay development, preclinical and pre-formulation support. Primary therapeutic areas supported were cardiovascular and infectious disease.-Investigated and characterized different liposome drug delivery systems-Pre-formulations (solubility, stability and dissolution testing); ELISA development-Investigated the use of Caco-2 cells as a model.

Feb 1992 - Aug 1993
2 education records

Tom Stephan education

Doctor Of Philosophy (Ph.D.), Pharmacology

University Of Mn-Minneapolis

Bachelor'S Of Science, Biochemistry And Molecular Biology (Topical Minor In Human Relations)

University Of Wisconsin-Eau Claire
FAQ

Frequently asked questions about Tom Stephan

Quick answers generated from the profile data available on this page.

What company does Tom Stephan work for?

Tom Stephan works for Biohaven Pharma.

What is Tom Stephan's role at Biohaven Pharma?

Tom Stephan is listed as Director, DMPK Scientist at Biohaven Pharma.

What is Tom Stephan's email address?

AeroLeads has found 1 work email signal at @criver.com for Tom Stephan at Biohaven Pharma.

Where is Tom Stephan based?

Tom Stephan is based in Durham, Connecticut, United States while working with Biohaven Pharma.

What companies has Tom Stephan worked for?

Tom Stephan has worked for Biohaven Pharma, Te Stephan Jr., Llc, Qed Therapeutics, Charles River Laboratories, and Te Stephan Jr, Llc.

How can I contact Tom Stephan?

You can use AeroLeads to view verified contact signals for Tom Stephan at Biohaven Pharma, including work email, phone, and LinkedIn data when available.

What schools did Tom Stephan attend?

Tom Stephan holds Doctor Of Philosophy (Ph.D.), Pharmacology from University Of Mn-Minneapolis.

What skills is Tom Stephan known for?

Tom Stephan is listed with skills including Craft, Art, Engraving, Handmade Jewelry, Laser Engraving, Small Business, Customer Service, and Management.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.